Improving Bordetella pertussis isolation from PCR positive samples: Impact of modified Regan-Lowe agar, sample Ct value and transport time on culture positivity
Objectives: Pertussis diagnosis relies mainly on PCR tests due to their higher sensitivity and faster results than culture methods.This led to a shortage of clinical isolates for resistance testing and genomic surveillance.Data on factors affecting strain recovery and on culture medium optimization are limited.This study validated the sensitivity of a modified Regan-Lowe agar for Bordetella recovery and assessed the impact of transport medium, transport time and Ct values on culture positivity.Methods: 500 PCR-positive respiratory samples from Austria and Germany were prospectively cultured on conventional Regan-Lowe agar and an in-house prepared variant supplemented with vancomycin.All plates were examined for Bordetella-suspicious colonies and confirmed by MALDI-TOF MS.Transport time, Ct values and transport media were compared between culture-positive and -negative samples.Results: Bordetella spp.were isolated from 167/500 (33 %) samples.82 isolates (16 %) were recovered from the conventional agar, whereas 160 isolates (32 %) were obtained from the plates with vancomycin.Mean transport time for culture-positive samples was 3.9 days vs. 7.9 days for culture-negative samples; mean Ct values 23.1 and Ct 29.2, respectively.Flocked swabs in Amies transport medium (eSwab) showed the highest recovery.For short transport times, Universal Transport Medium (UTM) was a valid alternative.Multivariable analysis confirmed Ct value, transport time and transport medium as independent predictors of culture-positivity. Conclusion:The addition of vancomycin to Regan-Lowe agar doubled the probability of isolation of Bordetella from PCR-positive samples.Our findings define key parameters to optimize culture recovery for molecular epidemiology and surveillance.
Authors
- Gabriel E. Wagner (ORCID: https://orcid.org/0000-0002-5704-3955)
- Petra Apfalter
- Michaela Lipp
- Josefa Luxner (ORCID: https://orcid.org/0009-0002-6579-5089)
- Kinga Rigler-Hohenwarter
- Karl Dichtl (ORCID: https://orcid.org/0000-0001-5032-8870)
- Barbara Kleinhappl
- Rainer Gattringer
- Heidrun Kerschner (ORCID: https://orcid.org/0000-0002-9094-371X)
- Ivo Steinmetz (ORCID: https://orcid.org/0000-0003-0510-7336)
- Isabel Klugherz (ORCID: https://orcid.org/0009-0003-6947-2487)
- D. Scott Schmid
- Eva Leitner
- Donna Diane Simeoni
Institutions
- Medical University of Graz (AT)
- Robert Koch Institute (DE)
- Krankenhaus der Elisabethinen (AT)
- Klinikum Wels-Grieskirchen (AT)
- Krankenhaus der Elisabethinen (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- CMI Communications
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.cmicom.2026.105191
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00